\-\ Texto\\:\\ \ \(0\)\
\-\ right\\ cheek\\ erythema\\ and\\ fullness\\.\ \(0\)\
\-\ management\\:\\ \ \(3\)\
\-\ \\â\\€\\“surveillance\\-\\ annual\\ skin\\ check\\,\\ jaw\\ panoramic\\,\\ brain\\ mr\\ \\(until\\ 8\\)\\,\\ periodic\\ tte\\,\\ avoid\\ ionizing\\ radiation\ \(0\)\
\-\ \\â\\€\\“treat\\ specific\\ complication\\:\\ eg\\.\\ odontogenic\\ keratocysts\\-\\ wide\\ excision\\ v\\.\\ marsupialization\\ \\ and\\ enucleation\\ \ \(0\)\
\-\ \\â\\€\\“avoid\\ radiation\\ tx\\ in\\ medulloblastoma\\-\\ induces\\ 100s\\ of\\ basal\\ cells\ \(0\)\
\-\ sinus\\ plain\\ film\\:\\ complete\\ opacification\\ of\\ right\\ maxillary\\ sinus\ \(0\)\
\-\ sinus\\ ct\\:\\ right\\ maxillary\\ sinus\\ expansive\\ fluid\\ containing\\ mass\\ and\\ thinning\\ of\\ the\\ boundaries\\ of\\ the\\ sinus\\;\\ impacted\\ teeth\\ in\\ the\\ maxillary\\ sinus\\;\\ bilateral\\ mandibular\\ cysts\ \(0\)\
\-\ mr\\ of\\ the\\ face\\:\\ multiple\\ t1\\ hypointense\\ and\\ t2\\ hyperintense\\ mandibular\\ cysts\\ and\\ expansile\\ maxillary\\ mucocele\ \(0\)\
\-\ basal\\ cell\\ nevus\\ syndrome\\;\\ gorlin\\-goltz\\ syndrome\ \(0\)\
\-\ multiple\\ odontogenic\\ cysts\\ is\\ pathognomonic\\ for\\ basal\\ cell\\ nevus\\ sydrome\ \(0\)\
\-\ 8\\ year\\ old\\ girl\\ with\\ right\\ malar\\ swelling\\ and\\ pain\\.\ \(1\)\
\-\ discussion\ \(89\)\
\-\ \\â\\€\\¢rare\\,\\ ad\\ inherited\\ mutation\\ in\\ ptch1\\ gene\\-\\ tumor\\ suppressor\\ gene\\ of\\ sonic\\ hedge\\ hog\\ pathway\ \(0\)\
\-\ \\â\\€\\¢multiple\\ nevoid\\ basal\\ cell\\ cancers\\,\\ meduloblastomas\\,\\ odontogenic\\ keratocysts\\,\\ cardiac\\ and\\ ovarian\\ fibromas\\-age\\ of\\ onset\\ differs\ \(0\)\
\-\ \\â\\€\\¢physical\\ exam\\:\\ craniofacial\\ abnormalities\\ \\(mild\\ hypertelorism\\,\\ macrocephaly\\)\\,\\ bifid\\ ribs\\,\\ palmar\\-plantar\\ pitting\\,\\ cleft\\ lip\\/palat\\,\\ polydactyly\\,\\ cataracts\\ and\\ glaucoma\ \(0\)\
\-\ \\â\\€\\¢calcified\\ cerebral\\ falx\\,\\ bridging\\ of\\ sella\\ \ \(0\)\
\-\ \\â\\€\\¢odontogenic\\ keratocysts\\-\\ neoplastic\\,\\ locally\\ destructive\\,\\ aggressive\\,\\ recur\ \(0\)\
\-\ \\â\\€\\¢clinical\\ diagnosis\\ supported\\ by\\ high\\ level\\ of\\ expression\\ of\\ ptch\\ 1\\ on\\ keratocysts\\ \ \(0\)\
\-\ references\ \(24\)\
\-\ \\â\\€\\¢x\\.\\-m\\.\\ gu1\\,\\ h\\.\\-s\\.\\ zhao2\\*\\,l\\.\\-s\\.\\ sun1\\,\\ and\\ t\\.\\-j\\.\\ li\\.\\ ptch\\ mutations\\ in\\ sporadic\\ and\\ gorlin\\-syndrome\\-related\\ odontogenic\\ keratocysts\\.\\ j\\ dent\\ res\\ 85\\(9\\)\\:859\\-863\\,\\ 2006\ \(0\)\
\-\ \\â\\€\\¢benjamin\\ barankin\\,\\ md\\,\\ frcpc\\ and\\ gary\\ goldenberg\\,\\ md\\ nevoid\\ basal\\ cell\\ carcinoma\\ syndrome\\.\\ uptodate\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ odontogenic\\:\\ 0\\.08571885225072685\ \(0\)\
\-\ keratocysts\\:\\ 0\\.08123059089787776\ \(0\)\
\-\ basal\\:\\ 0\\.06834276312523462\ \(0\)\
\-\ sinus\\:\\ 0\\.06579282041352501\ \(0\)\
\-\ maxillary\\:\\ 0\\.06557731505368374\ \(0\)\
\-\ keratocysts\\-\\:\\ 0\\.061863287185729816\ \(0\)\
\-\ nevoid\\:\\ 0\\.061863287185729816\ \(0\)\
\-\ ptch\\:\\ 0\\.061863287185729816\ \(0\)\
\-\ nevus\\:\\ 0\\.041200557507368826\ \(0\)\
\-\ mandibular\\:\\ 0\\.03711689753930061\ \(0\)\
\-\ cysts\\:\\ 0\\.03523640297717228\ \(0\)\
\-\ cell\\:\\ 0\\.03239636086430156\ \(0\)\
\-\ \\â\\€\\“surveillance\\-\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\“treat\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\“avoid\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ medulloblastoma\\-\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ 100s\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ gorlin\\-goltz\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\¢rare\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ ptch1\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ gene\\-\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ suppressor\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ hedge\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ hog\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ meduloblastomas\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ fibromas\\-age\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\¢physical\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ palmar\\-plantar\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ lip\\/palat\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\¢calcified\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\¢odontogenic\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\¢clinical\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\¢x\\.\\-m\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ gu1\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ h\\.\\-s\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ zhao2\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ l\\.\\-s\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ sun1\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ t\\.\\-j\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ gorlin\\-syndrome\\-related\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\:859\\-863\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\â\\€\\¢benjamin\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ barankin\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ frcpc\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ goldenberg\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ md\\:\\ 0\\.029616832097066025\ \(0\)\
\-\ panoramic\\:\\ 0\\.028499548222479132\ \(0\)\
\-\ sonic\\:\\ 0\\.028499548222479132\ \(0\)\
\-\ marsupialization\\:\\ 0\\.027076863632625923\ \(0\)\
\-\ expansive\\:\\ 0\\.027076863632625923\ \(0\)\
\-\ boundaries\\:\\ 0\\.027076863632625923\ \(0\)\
\-\ hypertelorism\\:\\ 0\\.027076863632625923\ \(0\)\
\-\ dent\\:\\ 0\\.027076863632625923\ \(0\)\
\-\ bifid\\:\\ 0\\.02606745285209336\ \(0\)\
\-\ cataracts\\:\\ 0\\.02606745285209336\ \(0\)\
\-\ syndrome\\:\\ 0\\.025725332386680438\ \(0\)\
\-\ induces\\:\\ 0\\.025284493022920695\ \(0\)\
\-\ sydrome\\:\\ 0\\.025284493022920695\ \(0\)\
\-\ malar\\:\\ 0\\.025284493022920695\ \(0\)\
\-\ ionizing\\:\\ 0\\.02464476826224015\ \(0\)\
\-\ craniofacial\\:\\ 0\\.02464476826224015\ \(0\)\
\-\ polydactyly\\:\\ 0\\.02464476826224015\ \(0\)\
\-\ \\â\\€\\¢multiple\\:\\ 0\\.024103888683898896\ \(0\)\
\-\ pitting\\:\\ 0\\.024103888683898896\ \(0\)\
\-\ \\:\\:\\ 0\\.023795259284014\ \(0\)\
\-\ \\,\\:\\ 0\\.023746496975200645\ \(0\)\
\-\ tte\\:\\ 0\\.023635357481707586\ \(0\)\
\-\ differs\\:\\ 0\\.023635357481707586\ \(0\)\
\-\ mutations\\:\\ 0\\.023635357481707586\ \(0\)\
\-\ res\\:\\ 0\\.023222083672386942\ \(0\)\
\-\ expression\\:\\ 0\\.022852397652534922\ \(0\)\
\-\ glaucoma\\:\\ 0\\.022517975969010975\ \(0\)\
\-\ 8\\:\\ 0\\.022421877601749813\ \(0\)\
\-\ v\\.\\:\\ 0\\.022212672891854378\ \(0\)\
\-\ pathway\\:\\ 0\\.022212672891854378\ \(0\)\
\-\ uptodate\\:\\ 0\\.022212672891854378\ \(0\)\
\-\ inherited\\:\\ 0\\.021931821285982322\ \(0\)\
\-\ macrocephaly\\:\\ 0\\.021931821285982322\ \(0\)\
\-\ \\;\\:\\ 0\\.02132022303634309\ \(0\)\
\-\ enucleation\\:\\ 0\\.020600278753684413\ \(0\)\
\-\ impacted\\:\\ 0\\.020600278753684413\ \(0\)\
\-\ locally\\:\\ 0\\.020600278753684413\ \(0\)\
\-\ cheek\\:\\ 0\\.02042030228214915\ \(0\)\
\-\ ad\\:\\ 0\\.02042030228214915\ \(0\)\
\-\ recur\\:\\ 0\\.02024910872365991\ \(0\)\
\-\ check\\:\\ 0\\.020085880598625202\ \(0\)\
\-\ gene\\:\\ 0\\.020085880598625202\ \(0\)\
\-\ supported\\:\\ 0\\.020085880598625202\ \(0\)\
\-\ bridging\\:\\ 0\\.019929909501885435\ \(0\)\
\-\ radiation\\:\\ 0\\.019678956137279553\ \(0\)\
\-\ sporadic\\:\\ 0\\.01936730371214796\ \(0\)\
\-\ jaw\\:\\ 0\\.019116570505193067\ \(0\)\
\-\ periodic\\:\\ 0\\.019116570505193067\ \(0\)\
\-\ mucocele\\:\\ 0\\.019116570505193067\ \(0\)\
\-\ mutation\\:\\ 0\\.019116570505193067\ \(0\)\
\-\ falx\\:\\ 0\\.019116570505193067\ \(0\)\
\-\ mr\\:\\ 0\\.019054031382080238\ \(0\)\
\-\ teeth\\:\\ 0\\.01888256568239071\ \(0\)\
\-\ tx\\:\\ 0\\.018558448769650304\ \(0\)\
\-\ cancers\\:\\ 0\\.01807704132574334\ \(0\)\
\-\ eg\\:\\ 0\\.017988206911763373\ \(0\)\
\-\ destructive\\:\\ 0\\.017988206911763373\ \(0\)\
\-\ thinning\\:\\ 0\\.01781701335327414\ \(0\)\
\-\ avoid\\:\\ 0\\.017348482151082836\ \(0\)\
\-\ sella\\:\\ 0\\.01727613377493288\ \(0\)\
\-\ 2006\\:\\ 0\\.01727613377493288\ \(0\)\
\-\ gary\\:\\ 0\\.01727613377493288\ \(0\)\
\-\ fullness\\:\\ 0\\.017135764179797095\ \(0\)\
\-\ 85\\:\\ 0\\.016745498793445432\ \(0\)\
\-\ \\*\\:\\ 0\\.016684475134807294\ \(0\)\
\-\ pathognomonic\\:\\ 0\\.016231100638386217\ \(0\)\
\-\ ribs\\:\\ 0\\.016178336156405376\ \(0\)\
\-\ wide\\:\\ 0\\.01607512954164645\ \(0\)\
\-\ li\\:\\ 0\\.015974872094474325\ \(0\)\
\-\ opacification\\:\\ 0\\.01587739993971266\ \(0\)\
\-\ neoplastic\\:\\ 0\\.015343393570091866\ \(0\)\
\-\ containing\\:\\ 0\\.015221689857853654\ \(0\)\
\-\ annual\\:\\ 0\\.015027785722151727\ \(0\)\
\-\ erythema\\:\\ 0\\.014738238270614873\ \(0\)\
\-\ complication\\:\\ 0\\.014703668809411322\ \(0\)\
\-\ face\\:\\ 0\\.014703668809411322\ \(0\)\
\-\ expansile\\:\\ 0\\.014703668809411322\ \(0\)\
\-\ aggressive\\:\\ 0\\.01466943661662057\ \(0\)\
\-\ cleft\\:\\ 0\\.014635535174825003\ \(0\)\
\-\ hypointense\\:\\ 0\\.014222261365504358\ \(0\)\
\-\ discussion\\:\\ 0\\.014046786205593265\ \(0\)\
\-\ ovarian\\:\\ 0\\.01372015314220375\ \(0\)\
\-\ j\\:\\ 0\\.013542776724088552\ \(0\)\
\-\ until\\:\\ 0\\.013168152248910638\ \(0\)\
\-\ right\\:\\ 0\\.012654480127865497\ \(0\)\
\-\ multiple\\:\\ 0\\.012630217568275572\ \(0\)\
\-\ references\\:\\ 0\\.012466063982672325\ \(0\)\
\-\ hyperintense\\:\\ 0\\.01244793075404621\ \(0\)\
\-\ specific\\:\\ 0\\.012394086649924595\ \(0\)\
\-\ 9\\:\\ 0\\.012394086649924595\ \(0\)\
\-\ excision\\:\\ 0\\.012306142900229099\ \(0\)\
\-\ cells\\:\\ 0\\.012022619979473676\ \(0\)\
\-\ skin\\:\\ 0\\.011516241878031502\ \(0\)\
\-\ film\\:\\ 0\\.011516241878031502\ \(0\)\
\-\ cardiac\\:\\ 0\\.011420479975266563\ \(0\)\
\-\ management\\:\\ 0\\.011314145415633829\ \(0\)\
\-\ abnormalities\\:\\ 0\\.011013209198941111\ \(0\)\
\-\ complete\\:\\ 0\\.010552196259600192\ \(0\)\
\-\ girl\\:\\ 0\\.010541675196455432\ \(0\)\
\-\ cerebral\\:\\ 0\\.010387531585137092\ \(0\)\
\-\ swelling\\:\\ 0\\.009988810049056605\ \(0\)\
\-\ plain\\:\\ 0\\.009737767412944156\ \(0\)\
\-\ t1\\:\\ 0\\.009503493109558751\ \(0\)\
\-\ onset\\:\\ 0\\.009464635880439123\ \(0\)\
\-\ brain\\:\\ 0\\.009022286046676358\ \(0\)\
\-\ level\\:\\ 0\\.008641715886480463\ \(0\)\
\-\ fluid\\:\\ 0\\.008521540717908256\ \(0\)\
\-\ carcinoma\\:\\ 0\\.008497991824617076\ \(0\)\
\-\ t2\\:\\ 0\\.008486276381580183\ \(0\)\
\-\ high\\:\\ 0\\.008205424775708126\ \(0\)\
\-\ mild\\:\\ 0\\.00789562615414434\ \(0\)\
\-\ \\(\\:\\ 0\\.0076038076446722155\ \(0\)\
\-\ \\)\\:\\ 0\\.0075109230748768956\ \(0\)\
\-\ bilateral\\:\\ 0\\.007276553436191032\ \(0\)\
\-\ 1\\:\\ 0\\.007134478484069147\ \(0\)\
\-\ tumor\\:\\ 0\\.006990288777581794\ \(0\)\
\-\ and\\:\\ 0\\.006947716010717204\ \(0\)\
\-\ diagnosis\\:\\ 0\\.006884980108001473\ \(0\)\
\-\ exam\\:\\ 0\\.006586785754208906\ \(0\)\
\-\ in\\:\\ 0\\.005914347089687789\ \(0\)\
\-\ by\\:\\ 0\\.004992529485069736\ \(0\)\
\-\ ct\\:\\ 0\\.004194047906638747\ \(0\)\
\-\ mass\\:\\ 0\\.004170038620868647\ \(0\)\
\-\ of\\:\\ 0\\.004087852659578541\ \(0\)\
\-\ pain\\:\\ 0\\.0036617830439674903\ \(0\)\
\-\ year\\:\\ 0\\.003354755330782157\ \(0\)\
\-\ old\\:\\ 0\\.003069945953902648\ \(0\)\
\-\ for\\:\\ 0\\.0025582742057639126\ \(0\)\
\-\ on\\:\\ 0\\.0025399684644400984\ \(0\)\
\-\ is\\:\\ 0\\.0019729500995955287\ \(0\)\
\-\ the\\:\\ 0\\.0019403408379456252\ \(0\)\
\-\ \\.\\:\\ 0\\.001370157533581786\ \(0\)\
\-\ with\\:\\ 0\\.00041054096873645524\ \(0\)\
